Taken together, these results suggest that although COVID-19 vaccine responses are largely similar between nonpregnant, pregnant, and lactating individuals, the vaccine may preferentially elicit more long-lived, stem-like SARS-CoV-2–specific CD4+ T cells when administered during pregnancy. This evidence concerns the gene CD4 and COVID-19.